News | July 05, 2023
Biocon Biologics expands footprint in emerging markets
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
Supply readiness follows months of manufacturing to ensure timely and ample supply
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Subscribe To Our Newsletter & Stay Updated
